Skip to main content
SpringerLink
Log in

Screening for Esophageal Cancer in High-Risk Groups

Barrett’s Esophagus

  • Chapter
Cancer Screening

Part of the book series: Current Clinical Practice ((CCP))

  • 117 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pope, CE II. (1973) Tumlors. In: Sleisenger MH, Fordtran JS, eds., Gastrointestinal Disease. Philadelphia: WB Sanders, p. 455.

    Google Scholar 

  2. Cedarquist C, Nielsen J, Berthelsen A, et al. (1971) Cancer of the esophagus. II. Therapy and outcome. Chir Scand 144: 233–240.

    Google Scholar 

  3. Craddock VW. (1992) Aetiology of oesophageal cancer: some operative factors. Eur J Cancer Prey 1: 89–103.

    Article  CAS  Google Scholar 

  4. Landis SH, Murray T, Bolden S, et al. (1998) Cancer statistics. CA Cancer J Clin 48: 6–29.

    Article  PubMed  CAS  Google Scholar 

  5. Raphael HA, Ellis FH Jr, Dockerty MB. (1996) Primary adenocarcinoma of the esophagus: 18-year review and review of the literature. Ann Surg 64 (5): 785–796.

    Google Scholar 

  6. Conio M, Cameron AJ. (1999) Barrett’s esophagus and adenocarcinoma: prevalence and incidence in Olmsted County. Gastroenterology 116 (G1): 682.

    Google Scholar 

  7. Devesa S, Blot WJ, Fraumeni J. (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049–2053.

    Article  PubMed  CAS  Google Scholar 

  8. Kim R, Rose S, Shar AO, et al. (1997) Extent of Barrett’s metaplasia: a prospective study of the serial change in area of Barrett’s measured by quantitative endoscopie imaging 1996. Gasrointest Endosc 45: 456–462.

    Article  CAS  Google Scholar 

  9. Devesa SS, Blot WJ, Fraumeni JF. (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049–2053.

    Article  PubMed  CAS  Google Scholar 

  10. Chalasani N, Wo JM, Waring JP. (1998) Racial differences in the histology, location, and risk factors of esophageal cancer. J Clin Gastroenterol 26: 11–13.

    Article  PubMed  CAS  Google Scholar 

  11. Provenzale D, Kemp JA, Arora S, et al. (1994) A guide for surveillance of patients with Barrett’s esophagus. Am J Gastroenterol 89: 670–680.

    PubMed  CAS  Google Scholar 

  12. Streitz JM, Ellis FH, Tilden RL, et al. (1998) Endoscopie surveillance of Barrett’s esophagus: a cost-effectiveness comparison with mammographie surveillance for breast cancer. Am J Gastroenterol 93: 911–915.

    Article  PubMed  Google Scholar 

  13. Lagergren J, Bergstrom R, Lindgren A, et al. (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825–831.

    Article  PubMed  CAS  Google Scholar 

  14. Spechler SJ, Goyal RK. (1986) Barrett’s esophagus. N Engl J Med 315: 362–371.

    Article  PubMed  CAS  Google Scholar 

  15. Champion G, Richter JE, Vaezi MF, et al. (1994) Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 107: 747–754.

    Article  PubMed  CAS  Google Scholar 

  16. Armstrong D, Blum AL, Savary M. (1982) Reflux disease and Barrett’s esophagus. Endoscopy 1972; 24: 9.

    Article  Google Scholar 

  17. Monnier PH, Ollyo J-B, Fontolliet CH, et al. (1995) Epidemiology and natural history of reflux esophagitis. Sem Laparosc Surg 2: 2–9.

    Google Scholar 

  18. Winters JR, Sparling TJ, Chobanian SJ, et al. (1987) Barrett’ s esophagus: a prevalent, occult complication of gastroesophageal disease. Gastroenterology 92: 118–124.

    PubMed  Google Scholar 

  19. Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus, HW. (1993) Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett’ s) esophagus: the Rotterdam Esophageal Tumor Study Group. Cancer 72: 1155–1158.

    Article  PubMed  CAS  Google Scholar 

  20. Hassall E, Weinstein WM, Ament ME. (1985) Barrett’s esophagus in childhood. Gastroenterology 89: 1331–1337.

    PubMed  CAS  Google Scholar 

  21. Cameron AJ, Lomboy CI. (1992) Barrett’s esophagus: age, prevalence, and extent of columelium. Gastroenterology 103: 1241–1245.

    PubMed  CAS  Google Scholar 

  22. Brown LM, Silvennan DT, Pottern LM, et al. (1994) Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control 5: 333–340.

    Article  PubMed  CAS  Google Scholar 

  23. Brown LM, Swanson CA, Gridley C, et al. (1995) Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 87: 104–109.

    Article  PubMed  CAS  Google Scholar 

  24. Katzka BA, Reynolds JC, Saul Sll, et al. (1987) Barrett’s metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 82: 46–52.

    Article  PubMed  CAS  Google Scholar 

  25. Garidou A, Tzonou A, Lipworth L, et al. (1996) Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Intl Cancer 68: 295–299.

    Article  CAS  Google Scholar 

  26. Harle IA, Finley RJ Belsheim M, et al. (1985) Management of adenocarcinoma in columnar-lined esophagus. Ann Thorac Surg 40: 330–336.

    Article  PubMed  CAS  Google Scholar 

  27. Levine DS, Haggitt RC, Blunt PL, et al. (1993) An endoscopie biopsy protocol on differentiate high-grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 105: 40–50.

    PubMed  CAS  Google Scholar 

  28. Locke CR III, Talley NJ, Fett SL, et al. (1998) Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112: 1448.

    Article  Google Scholar 

  29. Robertson CS, Mayberry IF, Nicholson DA, et al. (1988) Value of endoscopie surveillance in the detection of neoplastic changes in Barrett’s esophagus. BrJ Surg 75: 760–773.

    Article  CAS  Google Scholar 

  30. Hammeeteman W, Tytgat IN, Houthoff HI, et al. (1989) Barrett’ s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 69: 1249–1256.

    Google Scholar 

  31. Miros M,Kerlin P, Walker N. (1991) Only patients with dysplasia progress to adenocarcinoma in Barrett’s esophagus. Gut 32: 1441–1446.

    Article  PubMed  CAS  Google Scholar 

  32. Reid BJ, Blount PL, Rubin CE, et al. (1992) Flow cytometric and histological progression to malignancy in Barrett’s esophagus: prospective endoscopie surveillance of a cohort. Gastroenterology 102: 1212–1219.

    PubMed  CAS  Google Scholar 

  33. Reid BJ, Haggitt R C, Rubin CE, et al. (1988) Observer variations in the diagnosis of dysplasia in Barrett’s esophagus. Human Pathol 19: 166–178.

    Article  CAS  Google Scholar 

  34. Hirota W K, Loughney T M, Lazas DJ, et al. (1999) Specialized intestinal metaplasia, dysplasia, and cancer of esophagus and esophagogasric junction: prevalence and clinical data. Gastroenterology 116: 277–285.

    Article  PubMed  CAS  Google Scholar 

  35. Sharma P, Morales T G, Bhattacharyya A, et al. (1997) Dysplasia in short-segment Barrett’s esophagus: a prospective 3 year follow up. Am J Gastroentrol 92: 2012–2016.

    CAS  Google Scholar 

  36. Weston A P, Krmpotich P T, Cherian R, et al. (1997) Prospective long term endoscopie and histologic follow-up of short segment Barrett’ s esophagus: comparison with traditional long segment Barrett’ s esophagus. Am J Gastroenterol 92: 407–413.

    PubMed  CAS  Google Scholar 

  37. Garewal HS, Sampliner R, LiuY, Trent JM. (1989) Chromosomal rearrangement in Barrett’ s esophagus: a pre-malignant lesion of esophageal adenocarcinoma. Cancer Genet Cyto-genet 42: 281.

    Article  CAS  Google Scholar 

  38. Grawal HS, Sampliner R, Gerner E, et al. (1988) Ornithine decarboxylase activity in Barrett’s esophagus: a potential marker for dysplasia. Gastroentrology 94: 819.

    Google Scholar 

  39. Schneider PM, Casson AG, Levin B, et al. (1996) Mutations of p53 in Barrett’s esophagus and Barrett’s cancer: a prospective study of ninety eighty cases. JThorac Cardiovasc Surg 111: 323.

    Article  CAS  Google Scholar 

  40. Falk GW, Rice TW, Goldblum JR, Richter JE. (1999) Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett’s esophagus with high-grade dysplasia. Gastrointest Endosc 49 (2): 170–176.

    Article  PubMed  CAS  Google Scholar 

  41. Sampliner RE. (1998) Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93 (7): 1028–1032.

    Article  PubMed  CAS  Google Scholar 

  42. ASGE. (1998) The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Gastrointest Endosc 48 (6): 663–668.

    Article  Google Scholar 

  43. Falk GW, Chittajallu R, Goldblum JR, et al. (1997) Surveillance of patients with Barrett’ s esophagus for dysplasia and cancer with balloon cytology [see comments]. Gastroenterology 112 (6): 1787–1797.

    Article  PubMed  CAS  Google Scholar 

  44. Fennerty MB, DiTomasso J, Morales TG, et al. (1995) Screening for Barrett’s esophagus by balloon cytology. Am J Gastroenterol 90 (8): 1230–1232.

    PubMed  CAS  Google Scholar 

  45. Sugimachi K, Kitamura K, Baba K, et al. (1992) Endoscopie diagnosis of early carcinoma using Lugol’s solution. Gastrointest Endosc 38: 657–661.

    Article  PubMed  CAS  Google Scholar 

  46. Woolf GM, Riddell RH, Irvine EJ, et al. (1989) A study to examine agreement between endoscopy and histology for the diagnosis of columnar lined (Barrett’s) esophagus. Gastrointest Endosc 35: 541–544.

    Article  PubMed  CAS  Google Scholar 

  47. Chobanian SJ, Catau EL, Winters C, et al. (1987) In vivo staining with toluidine blue as an adjunct to the endoscopie detection of Barrett’s esophagus. Gastrointest Endosc 33: 99–101.

    Article  PubMed  CAS  Google Scholar 

  48. Canto MI, Setrakian S, Petras RE, et al. (2001) Methylene blue staining of dysplastic and nondysplastic Barrett’s esophagus. An in vivo and ex vivo study. Gastrointest Endosc,in press.

    Google Scholar 

  49. Canto MI, Setrakian S, Willis J, et al. (2000) Methylene blue-directed biopsy for improved detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: a controlled sequential trial. Gastrointest Endosc 51 (5): 560–568.

    Article  PubMed  CAS  Google Scholar 

  50. Ohno S, Kabashima A, Tomoda M, et al. (1997) Significance of routine annual esophagram for early detection of carcinoma of the esophagus. Hepato-Gastroenterology 44: 539–545.

    PubMed  CAS  Google Scholar 

  51. Adrain AL, Ter HC, Cassidy MJ, et al. (1997) High-resolution endoluminal sonography is a sensitive modality for the identification of Barrett’s metaplasia. Gastrointest Endosc 46 (2): 147–151.

    Article  PubMed  CAS  Google Scholar 

  52. Stotland B, Kochman M, Smith D, et al. (1997) Endosonography is indicated for selected patients with Barrett’s esophagus. Gastrointest Endosc 45(4):AB 181.

    Google Scholar 

  53. Parent J, Levine D, Haggitt R, et al. (1997) Role of endoscopie ultrasound in patients with Barrett’s esophagus and high grade dysplasia. Gastrointest Endosc 45(4):AB76.

    Google Scholar 

  54. Bremner CG, Deemester TR. (1997) Proceedings from an international conference on ablation therapy for Barrett’s mucosa. Dis Esophagus 11:1–27.

    Google Scholar 

  55. Dent J. (1991) Working party report to the world congresses of gastronenterology, Sydney 1990: Barrett’s oesophagus. J Gastroenterol Hepatol 6:1–22.

    Article  PubMed  CAS  Google Scholar 

  56. Sandick JW, Lanschot JJ, Kuiken BW, et al. (1998) Impact of endoscopie biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 43: 216–222.

    Article  PubMed  Google Scholar 

  57. Peters JH, Clark GW, Ireland AP, et al. (1994) Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 05: 813–821.

    Google Scholar 

  58. McCallum RW, Polpalle S, Davenport K, et al. (1991) Role of anti-reflux surgery against dysplasia in Barrett’s esophagus. Gastroenterology 100: 100–106.

    Google Scholar 

  59. McDonald MI, Trastek VF, Allen MS, et al. (1996) Barrett’s esophagus: does an antireflux procedure reduce the need for endoscopie surveillance? J Thorac Cardiovasc Surg 111: 1135–1138.

    Article  PubMed  CAS  Google Scholar 

  60. Overholt B, Panjehpour M, Haydek J. (1999) Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 49: 1–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Elisabeth I. Heath MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcia I. F. Canto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Newington VA Medical Center, Newington, CT, USA

    Khalid Aziz MBBS, MRCP (UK), MRCP (IRE), FACG

  2. University of Connecticut School of Medicine, Farmington, CT, USA

    George Y. Wu MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Heath, E.I., Canto, M.I.F. (2002). Screening for Esophageal Cancer in High-Risk Groups. In: Aziz, K., Wu, G.Y. (eds) Cancer Screening. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-191-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-191-6_13

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-229-2

  • Online ISBN: 978-1-59259-191-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation